130 related articles for article (PubMed ID: 22456614)
1. Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines.
Takeda M; Ikeda M; Ariumi Y; Wakita T; Kato N
J Gen Virol; 2012 Jul; 93(Pt 7):1422-1431. PubMed ID: 22456614
[TBL] [Abstract][Full Text] [Related]
2. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
[TBL] [Abstract][Full Text] [Related]
3. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
[TBL] [Abstract][Full Text] [Related]
4. Efficient replication systems for hepatitis C virus using a new human hepatoma cell line.
Kato N; Mori K; Abe K; Dansako H; Kuroki M; Ariumi Y; Wakita T; Ikeda M
Virus Res; 2009 Dec; 146(1-2):41-50. PubMed ID: 19720094
[TBL] [Abstract][Full Text] [Related]
5. Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells.
Bungyoku Y; Shoji I; Makine T; Adachi T; Hayashida K; Nagano-Fujii M; Ide YH; Deng L; Hotta H
J Gen Virol; 2009 Jul; 90(Pt 7):1681-1691. PubMed ID: 19282429
[TBL] [Abstract][Full Text] [Related]
6. Cell Culture Systems of HCV Using JFH-1 and Other Strains.
Wakita T
Cold Spring Harb Perspect Med; 2019 Nov; 9(11):. PubMed ID: 31501261
[TBL] [Abstract][Full Text] [Related]
7. Genetic characterization of hepatitis C virus in long-term RNA replication using Li23 cell culture systems.
Kato N; Sejima H; Ueda Y; Mori K; Satoh S; Dansako H; Ikeda M
PLoS One; 2014; 9(3):e91156. PubMed ID: 24625789
[TBL] [Abstract][Full Text] [Related]
8. Genotype 1a HCV (H77S) infection system.
Yi M; Lemon SM
Methods Mol Biol; 2009; 510():337-46. PubMed ID: 19009273
[TBL] [Abstract][Full Text] [Related]
9. Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.
Aligeti M; Roder A; Horner SM
J Virol; 2015 Nov; 89(22):11523-33. PubMed ID: 26355084
[TBL] [Abstract][Full Text] [Related]
10. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
[TBL] [Abstract][Full Text] [Related]
11. A novel helper-dependent adenovirus-based cell culture model for Hepatitis C virus replication and production.
Zhou X; Zeng Y; Li J; Guo Y; Fu Y; He J; Sun S; Zhou Y
Virol J; 2013 Aug; 10():273. PubMed ID: 23987099
[TBL] [Abstract][Full Text] [Related]
12. Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations.
Scheel TK; Gottwein JM; Carlsen TH; Li YP; Jensen TB; Spengler U; Weis N; Bukh J
J Virol; 2011 Mar; 85(6):2891-906. PubMed ID: 21177811
[TBL] [Abstract][Full Text] [Related]
13. Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA.
Sejima H; Mori K; Ariumi Y; Ikeda M; Kato N
Virus Res; 2012 Jul; 167(1):74-85. PubMed ID: 22579597
[TBL] [Abstract][Full Text] [Related]
14. Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.
Helle F; Brochot E; Fournier C; Descamps V; Izquierdo L; Hoffmann TW; Morel V; Herpe YE; Bengrine A; Belouzard S; Wychowski C; Dubuisson J; Francois C; Regimbeau JM; Castelain S; Duverlie G
PLoS One; 2013; 8(8):e70809. PubMed ID: 23940646
[TBL] [Abstract][Full Text] [Related]
15. Patient-derived hepatitis C virus and JFH-1 clones differ in their ability to infect human hepatoma cells and lymphocytes.
Sarhan MA; Chen AY; Russell RS; Michalak TI
J Gen Virol; 2012 Nov; 93(Pt 11):2399-2407. PubMed ID: 22855787
[TBL] [Abstract][Full Text] [Related]
16. New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication.
Ueda Y; Takeda M; Mori K; Dansako H; Wakita T; Kim HS; Sato A; Wataya Y; Ikeda M; Kato N
PLoS One; 2013; 8(8):e72519. PubMed ID: 24023620
[TBL] [Abstract][Full Text] [Related]
17. Establishment of Replication-Competent HCV Strain with Minimum Modifications.
Kato T; Murayama A; Wakita T
Methods Mol Biol; 2019; 1911():73-83. PubMed ID: 30593618
[TBL] [Abstract][Full Text] [Related]
18. Single strain isolation method for cell culture-adapted hepatitis C virus by end-point dilution and infection.
Sugiyama N; Murayama A; Suzuki R; Watanabe N; Shiina M; Liang TJ; Wakita T; Kato T
PLoS One; 2014; 9(5):e98168. PubMed ID: 24848954
[TBL] [Abstract][Full Text] [Related]
19. Novel permissive cell lines for complete propagation of hepatitis C virus.
Shiokawa M; Fukuhara T; Ono C; Yamamoto S; Okamoto T; Watanabe N; Wakita T; Matsuura Y
J Virol; 2014 May; 88(10):5578-94. PubMed ID: 24599999
[TBL] [Abstract][Full Text] [Related]
20. NS3 from Hepatitis C Virus Strain JFH-1 Is an Unusually Robust Helicase That Is Primed To Bind and Unwind Viral RNA.
Zhou T; Ren X; Adams RL; Pyle AM
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]